• Envoy Medical reported new patent issuances in Australia and Europe covering fully implanted cochlear implant technology, expanding its intellectual property position in implant design, signal analysis, and rechargeable battery safety.
• Australia granted Patent No. 2022227537 on July 3, 2025 for a cochlear implant system using a removable earplug sensor paired with an implanted rechargeable battery.
• Europe granted Patents No. 4297848 and 4297851 on April 8, 2026 covering signal indication and integrated signal analysis functions in a fully implantable cochlear implant system.
• A separate European patent, No. 4297862, is expected to be granted on June 10, 2026 for implanted battery recharging methods designed to manage heat exposure during charging.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202605200830NEWSFILECNPR____20260520_298064_1) on May 20, 2026, and is solely responsible for the information contained therein.